EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced response to SARS-CoV-2 vaccination is associated with impaired immunoglobulin class switch recombination in SLE patients

Guillem Montamat iD, Claire E Meehan iD, Hannah F Bradford iD, Reşit Yıldırım, Francisca Guimarães iD, Marina Johnson, David Goldblatt, David A Isenberg, Claudia Mauri iD

Clinical and Experimental Immunology · 21.01.2025 · 219 (1)

DOI: 10.1093/cei/uxae119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 10.12.2024. Verfasst von Guillem Montamat und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infection and Immunity and Institute of Immunity and Transplantation, Royal Free Hospital, University College London, London, UK. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, SARS-CoV-2, Immunoglobulin Class Switching, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LUPUS UK, Versus Arthritis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Systemic lupus erythematosus (SLE) patients exhibit B-cell abnormalities. Although there are concerns about reduced antibody responses to SARS-CoV-2 vaccines, detailed data on B-cell-specific responses in SLE remain scarce. Understanding the responsiveness to novel vaccine antigens, and boosters number, is important to avoid unnecessarily prolonged isolation of immunocompromised individuals. We assessed humoral and antigen-specific B-cell subset responses, including changes in isotype switching, prior to and after several doses of SARS-CoV-2 vaccines.

Methods

Blood samples were obtained prior to and after SARS-CoV-2 vaccination from cross-sectional and longitudinal cohorts of previously uninfected patients with SLE (n = 93). Healthy participants receiving SARS-CoV-2 vaccines were recruited as controls (n = 135). We measured serum antibody titres, their neutralizing capacity, and vaccine-specific memory B-cell subsets.

Results

Impaired IgG, IgA, and neutralizing responses against the original and various SARS-CoV-2 variants were observed following two doses of vaccine in SLE patients. Follow-up booster doses increased humoral responses compared to baseline, but they remained lower, with poorer neutralisation capacity against most strains, compared to healthy individuals after three or more doses. Analysis of memory B-cell subsets in SLE patients revealed an increase of SARS-CoV-2-specific isotype unswitched IgM+ over SARS-CoV-2-specific isotype switched IgG+/IgA+ memory B-cells compared to healthy individuals. Culturing healthy naive B-cells with high levels of IFNα, a hallmark of SLE pathogenesis, prevented B-cells from switching to IgG under IgG-polarizing conditions.

Conclusion

SLE patients’ protection against SARS-CoV-2 is overall impaired compared to healthy individuals and is associated with a class switch defect possibly due to chronic exposure of B-cells to IFNα.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicSARS-CoV-2Immunoglobulin Class SwitchingCOVID-19COVID-19 VaccinesHumansFemaleMaleAdultMiddle AgedAntibodies, ViralCross-Sectional StudiesImmunoglobulin GAntibodies, NeutralizingVaccinationLongitudinal StudiesImmunoglobulin AB-Lymphocyte SubsetsMemory B CellsB-LymphocytesImmunologic Memory

Stichwörter der Autor:innen

systemic lupus erythematosusvaccinationvaccine

Substanzen

Antibodies, ViralImmunoglobulin GCOVID-19 VaccinesAntibodies, NeutralizingImmunoglobulin A

Autor:innen und Institutionen

  • Division of Infection and Immunity and Institute of Immunity and Transplantation, Royal Free Hospital, University College London, London, UK.
  • Centre for Rheumatology, Division of Medicine, University College London Hospital, London, UK.
  • Great Ormond Street Institute of Child Health Biomedical Research Centre, University College London, London, UK.

ORCID-Profile: Guillem Montamat, Claire E Meehan, Hannah F Bradford, Francisca Guimarães, Claudia Mauri

Förderung

  • LUPUS UK
  • Versus Arthritis

Zitieren

APA

Montamat, G., Meehan, C. E., Bradford, H. F., Yıldırım, R., Guimarães, F., Johnson, M., Goldblatt, D., Isenberg, D. A., & Mauri, C. (2025). Reduced response to SARS-CoV-2 vaccination is associated with impaired immunoglobulin class switch recombination in SLE patients. Clinical and Experimental Immunology, 219(1). https://doi.org/10.1093/cei/uxae119

Vancouver

Montamat G, Meehan CE, Bradford HF, Yıldırım R, Guimarães F, Johnson M, et al. Reduced response to SARS-CoV-2 vaccination is associated with impaired immunoglobulin class switch recombination in SLE patients. Clinical and Experimental Immunology. 2025;219(1). doi:10.1093/cei/uxae119

BibTeX
@article{Montamat2025,
  author = {Montamat, Guillem and Meehan, Claire E and Bradford, Hannah F and Yıldırım, Reşit and Guimarães, Francisca and Johnson, Marina and Goldblatt, David and Isenberg, David A and Mauri, Claudia},
  title = {Reduced response to SARS-CoV-2 vaccination is associated with impaired immunoglobulin class switch recombination in SLE patients},
  journal = {Clinical and Experimental Immunology},
  year = {2025},
  volume = {219},
  number = {1},
  doi = {10.1093/cei/uxae119}
}
Kostenlos starten →